LianMedical
Cash Flow Statement
| Line Item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-110.3M | $-196.3M | $-139.6M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $1.0M | $525.0K | $76.0K |
| Amortization | — | — | — |
| Stock-Based Compensation | $19.1M | $8.7M | $5.2M |
| Net Cash from Operating Activities | $-99.2M | $-164.0M | $-98.1M |
| Investing Activities | |||
| Capital Expenditures | $1.8M | $947.0K | $886.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-69.2M | $-155.9M | $-886.0K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $1.7M | $313.3M | $309.8M |
| Net Change in Cash | $-168.9M | $-6.2M | $211.1M |
| Free Cash Flow | $-101.0M | $-164.9M | $-99.0M |